ACM Research vs Amtech Systems
ACMR and ASYS side by side, both in special industry machinery, except metalworking. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ACMR and ASYS compare
ACM Research is the larger company, worth 16 times as much as Amtech Systems ($3.3B against $211M).
On earnings, ACM Research is cheaper: it trades at 29.8× trailing earnings, against 46.4× for Amtech Systems.
ACM Research grew revenue faster over the last twelve months (29.1% versus −2.4% for Amtech Systems).
ACM Research keeps more of each dollar of sales as profit, with a net margin of 10.2% compared with 4.9% at Amtech Systems.
ACM Research scores higher on the StockData Score (14 against 11 for Amtech Systems), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ACMR | ASYS |
|---|---|---|
| Size and price | ||
| Market cap | $3.3B | $211M |
| Share price | $47.95 | $12.07 |
| Change, 1 year | 41.8% | 59.0% |
| Change, 5 years | 49.5% | 9.4% |
| Beta (5Y) | 1.97 | 1.22 |
| Employees | 2,513 | 264 |
| StockData Score | ||
| Total score | 14 (better) | 11 |
| Valuation score | 2 (better) | 1 |
| Growth score | 3 (better) | 1 |
| Performance score | 4 (better) | 3 |
| Health score | 5 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 29.8× (better) | 46.4× |
| P/S | 2.9× | 2.6× (better) |
| P/B | 1.8× (better) | 1.8× |
| EV/EBITDA | 17.6× | 14.2× (better) |
| P/FCF | – | 24.2× |
| PEG | 0.92 | – |
| FCF yield | −6.0% | 4.1% (better) |
| Fair value | $44.99 | $10.00 |
| Margin of safety | −6.6% (better) | −20.7% |
| Growth | ||
| Revenue growth (TTM) | 29.1% (better) | −2.4% |
| Revenue growth, 5Y average | 41.9% (better) | 3.9% |
| Net income growth (TTM) | −1.0% | – |
| EPS growth (TTM) | −7.5% | – |
| EPS growth, 5Y average | 35.5% | – |
| Profitability | ||
| Gross margin | 43.5% | 46.9% (better) |
| Operating margin | 14.5% (better) | 8.1% |
| Net margin | 10.2% (better) | 4.9% |
| FCF margin | −17.5% | 10.7% (better) |
| Return on equity | 7.0% (better) | 4.8% |
| Return on invested capital | 15.0% (better) | 11.8% |
| Financial health | ||
| Debt / equity | 0.18 (better) | 0.00 |
| Net debt / EBITDA | −3.25 | – |
| Interest coverage | 22.4× | 265× (better) |
| Current ratio | 3.16 | 5.41 (better) |
| Altman Z-score | 3.12 | 3.89 (better) |
| Piotroski F-score | 2 | 2 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 69.7% | 64.6% |
| Held by insiders | 5.2% | 18.7% |
| Insider net buying, 12 months | −$50.2M | $77.8K (better) |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 4.5% | 10.1% |
Go deeper
- ACMR stock overview
- ACMR income statement
- ACMR valuation and score
- ASYS stock overview
- ASYS income statement
- ASYS valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.